Mutual of America Capital Management LLC Has $2.44 Million Stock Holdings in STERIS plc (NYSE:STE)

Mutual of America Capital Management LLC decreased its position in STERIS plc (NYSE:STE) by 2.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 11,851 shares of the medical equipment provider’s stock after selling 320 shares during the period. Mutual of America Capital Management LLC’s holdings in STERIS were worth $2,436,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Franklin Resources Inc. boosted its stake in shares of STERIS by 171.2% in the 3rd quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider’s stock valued at $191,370,000 after purchasing an additional 529,308 shares during the last quarter. Boston Trust Walden Corp lifted its holdings in STERIS by 400.4% in the fourth quarter. Boston Trust Walden Corp now owns 224,741 shares of the medical equipment provider’s stock valued at $46,198,000 after buying an additional 179,829 shares during the period. Swedbank AB bought a new position in STERIS in the third quarter valued at approximately $28,251,000. Benjamin Edwards Inc. grew its holdings in STERIS by 2,123.2% during the 3rd quarter. Benjamin Edwards Inc. now owns 113,672 shares of the medical equipment provider’s stock worth $27,574,000 after acquiring an additional 108,559 shares during the period. Finally, Principal Financial Group Inc. raised its position in shares of STERIS by 9.5% during the 3rd quarter. Principal Financial Group Inc. now owns 1,114,224 shares of the medical equipment provider’s stock valued at $270,230,000 after acquiring an additional 96,336 shares during the last quarter. 94.69% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts have recently issued reports on STE shares. Stephens restated an “overweight” rating and issued a $240.00 price target on shares of STERIS in a research report on Thursday, February 6th. JMP Securities restated a “market outperform” rating and set a $265.00 target price on shares of STERIS in a report on Thursday, February 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a research note on Friday, November 8th. Finally, Piper Sandler lifted their price objective on shares of STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research note on Monday, February 3rd. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $258.75.

STERIS Stock Up 0.3 %

Shares of STERIS stock opened at $233.02 on Friday. STERIS plc has a 1 year low of $197.82 and a 1 year high of $248.24. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40. The company has a market capitalization of $22.89 billion, a P/E ratio of 49.47 and a beta of 0.92. The business has a 50-day moving average of $216.96 and a two-hundred day moving average of $222.85.

STERIS (NYSE:STE) last announced its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. As a group, equities analysts predict that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Investors of record on Thursday, February 20th will be paid a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a yield of 0.98%. The ex-dividend date of this dividend is Thursday, February 20th. STERIS’s payout ratio is presently 48.41%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.